Autopsy report · NCT04688658
Duvelisib in Combination With Nivolumab in Patients With Advanced Unresectable Melanoma
Cause of deathFunding or business
“Secura Bio, Inc. discontinued support of the trial.”
Life of this trial
- Registered 9 months before it started.
- Ran for about 3 years 4 months before it stopped.
- 13 participants enrolled.
- Results were posted on the registry 11 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 1, Phase 2
- Sponsor
- John Kirkwood
- Sponsor type
- University, hospital or other
- Conditions
- Unresectable Melanoma
- Interventions
- Nivolumab; Duvelisib
- Participants
- 13
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Evaluation of MST-188 in Acute Lower Limb Ischemia
“Program discontinued to persue alternate indications.” - Phase 3 Trial to Evaluate the Efficacy and Safety of DKP21102_B Added on to DKP21102_A Compared With DKP21102_A
“The clinical trial was withdrawn due to a commercial decision.” - A Study to Evaluate the Efficacy and Safety of Liso-cel Compared to Standard of Care in Adults With Relapsed or Refractory Follicular Lymphoma
“Replaced with another clinical trial.” - RNA Extraction and Amplification From Biopsy Specimens in Subjects With Metastatic Renal Cell Carcinoma (AGS-NTS-017)
“The sponsor's clinical program for the agent used in this study was discontinued.” - Surface EMG Biofeedback for Children With Cerebral Palsy
“The PI for this trial, which has been terminated, is no longer employed by USC. After repeated attempts of contact, we are unable to identify the PI's current employment. We would therefore request close out of this clinical trial record.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.